Moderna (MRNA) Total Debt (2025 - 2026)
Moderna (MRNA) posted quarterly Total Debt of $591.0 million for Q2 2026, little changed on a QoQ basis from $590.0 million in Q1 2026.
Moderna (MRNA) Total Debt (2025 - 2026) Analysis & Trends
Moderna has reported Total Debt for 2 years, with the latest figure at $591.0 million in Q2 2026.
- Total Debt for Q2 2026 came in at $591.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $591.0 million (changed N/A YoY), and the FY2025 annual result was $590.0 million, changed N/A from the prior year.
- Total Debt held at $591.0 million in Q2 2026, from $590.0 million in the prior quarter.
- Over five years, Total Debt peaked at $591.0 million in Q2 2026 and troughed at $590.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 591.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 591.00 Mn |
| Mar 31, 2026 | 590.00 Mn |
| Dec 31, 2025 | 590.00 Mn |